We are live on ! Find out more
Daiwa Securities Group

Daiwa Securities Group Portfolio holdings

AUM $34.8B
1-Year Est. Return 20.7%
This Fund
S&P 500
This Quarter Est. Return
-14.8%
1 Year Est. Return
+20.7%
3 Year Est. Return
+66.64%
5 Year Est. Return
+79.21%
10 Year Est. Return
+192.59%
AUM
$13.1B
AUM Growth
-$2.86B
Cap. Flow
-$262M
Cap. Flow %
-2%
Top 10 Hldgs %
37.9%
Holding
1,479
New
56
Increased
646
Reduced
399
Closed
58

Top Buys

Rank Stock Value
1
MAA icon
Mid-America Apartment Communities
MAA
+$174M
2
EQIX icon
Equinix
EQIX
+$83.3M
3
DLR icon
Digital Realty Trust
DLR
+$82.9M
4
PLD icon
Prologis
PLD
+$52.3M
5
INVH icon
Invitation Homes
INVH
+$39.6M

Top Sells

Rank Stock Value
1
AMT icon
American Tower
AMT
+$263M
2
VICI icon
VICI Properties
VICI
+$230M
3
ESS icon
Essex Property Trust
ESS
+$96.1M
4
VTR icon
Ventas
VTR
+$61.2M
5
EBIZ icon
Global X E-commerce ETF
EBIZ
+$39.2M

Sector Composition

Rank Sector Weight
1 Real Estate 60.75%
2 Technology 8.8%
3 Healthcare 4.18%
4 Consumer Discretionary 3.61%
5 Financials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ME
1226
DELISTED
23andMe Holding Co
ME
$2K ﹤0.01%
48
+16
+50% +$927
MORF
1227
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$2K ﹤0.01%
108
– –
KNTE
1228
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$2K ﹤0.01%
127
– –
NSTG
1229
DELISTED
NanoString Technologies, Inc.
NSTG
$2K ﹤0.01%
156
– –
TCDA
1230
DELISTED
Tricida, Inc. Common Stock
TCDA
$2K ﹤0.01%
207
+97
+88% +$923
RDUS
1231
DELISTED
Radius Health, Inc.
RDUS
$2K ﹤0.01%
177
+89
+101% +$662
ABSI icon
1232
Absci
ABSI
$1.28B
$1K ﹤0.01%
270
– –
ABUS icon
1233
Arbutus Biopharma
ABUS
$871M
$1K ﹤0.01%
395
– –
ACIU icon
1234
AC Immune
ACIU
$234M
$1K ﹤0.01%
158
– –
ADMA icon
1235
ADMA Biologics
ADMA
$1.97B
$1K ﹤0.01%
586
– –
AFMD
1236
DELISTED
Affimed
AFMD
$1K ﹤0.01%
41
– –
AKRO
1237
DELISTED
Akero Therapeutics
AKRO
$1K ﹤0.01%
119
– –
ALXO icon
1238
ALX Oncology
ALXO
$272M
$1K ﹤0.01%
138
– –
JBIO
1239
Jade Biosciences
JBIO
$1.21B
$1K ﹤0.01%
2
– –
BCYC
1240
Bicycle Therapeutics
BCYC
$276M
$1K ﹤0.01%
58
– –
BMEA icon
1241
Biomea Fusion
BMEA
$91.1M
$1K ﹤0.01%
+109
New +$638
BVS icon
1242
Bioventus
BVS
$843M
$1K ﹤0.01%
173
– –
CCCC icon
1243
C4 Therapeutics
CCCC
$397M
$1K ﹤0.01%
142
– –
CMPS
1244
Compass Pathways
CMPS
$1.52B
$1K ﹤0.01%
64
– –
COGT icon
1245
Cogent Biosciences
COGT
$6.91B
$1K ﹤0.01%
116
– –
CRBU icon
1246
Caribou Biosciences
CRBU
$158M
$1K ﹤0.01%
176
– –
DYN icon
1247
Dyne Therapeutics
DYN
$4.24B
$1K ﹤0.01%
150
– –
EWTX icon
1248
Edgewise Therapeutics
EWTX
$4.48B
$1K ﹤0.01%
144
– –
EYPT icon
1249
EyePoint Inc
EYPT
$1.04B
$1K ﹤0.01%
99
– –
FDMT icon
1250
4D Molecular Therapeutics
FDMT
$543M
$1K ﹤0.01%
94
– –
48 49
50
51 52

Similar funds

SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Daiwa Securities Group's Q2 2022 Portfolio in Review

As of Q2 2022, Daiwa Securities Group held 1,479 positions worth $13.1B, down 18% from $16B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Daiwa Securities Group's Q2 2022 filing shows 56 new, 646 increased, 399 reduced and 58 closed positions. Its largest new stake was HDFC Bank: 143,030 shares worth $3.93M. The largest sale was American Tower, an estimated $263M.

By sector, the portfolio is most concentrated in Real Estate at 61% of assets, up from 60% a quarter earlier, followed by Technology and Healthcare.

  • Daiwa Securities Group's largest Q2 2022 buy was HDFC Bank: 143,030 shares worth $3.93M.
  • Daiwa Securities Group added most to Mid-America Apartment Communities in Q2 2022, an estimated $174M increase.
  • Daiwa Securities Group's biggest Q2 2022 reduction was American Tower, cutting an estimated $263M.
  • Daiwa Securities Group fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $7.68M.
  • Daiwa Securities Group's ten largest holdings make up 38% of its $13.1B portfolio in Q2 2022.
  • Daiwa Securities Group opened 56 new positions and closed 58 in Q2 2022.
  • Daiwa Securities Group's portfolio value fell 18% quarter-over-quarter to $13.1B.

Based on Daiwa Securities Group's 13F filing for Q2 2022, filed 9 Aug 2022.